OTCMKTS:VASO Vaso (VASO) Stock Price, News & Analysis $0.12 0.00 (-3.71%) As of 01:47 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About Vaso Stock (OTCMKTS:VASO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vaso alerts:Sign Up Key Stats Today's Range$0.12▼$0.1250-Day Range$0.11▼$0.1352-Week Range$0.11▼$0.32Volume106,250 shsAverage Volume75,831 shsMarket Capitalization$20.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York. Read More Vaso Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks21st Percentile Overall ScoreVASO MarketRank™: Vaso scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Vaso. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Vaso is -11.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vaso is -11.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVaso has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Vaso's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the outstanding shares of Vaso have been sold short.Short Interest Ratio / Days to CoverVaso has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vaso has recently decreased by 75.79%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVaso does not currently pay a dividend.Dividend GrowthVaso does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.00% of the outstanding shares of Vaso have been sold short.Short Interest Ratio / Days to CoverVaso has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vaso has recently decreased by 75.79%, indicating that investor sentiment is improving significantly. News and Social Media0.9 / 5News SentimentN/A News SentimentVaso has a news sentiment score of -0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Vaso insiders have not sold or bought any company stock.Percentage Held by Insiders44.50% of the stock of Vaso is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Vaso's insider trading history. Receive VASO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vaso and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VASO Stock News HeadlinesVaso (OTCMKTS:VASO) versus Anteris Technologies Global (NASDAQ:AVR) Head to Head ContrastAugust 21, 2025 | americanbankingnews.comPfizer's sickle cell drug fails late-stage trialAugust 15, 2025 | msn.comThis stock could leave NVDA in the dustInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.August 29 at 2:00 AM | InvestorPlace (Ad)Pfizer's sickle-cell treatment efforts falter as drug fails studyAugust 15, 2025 | msn.comVaso Corporation reports Q2 revenue $20M vs. $20.2M last yearAugust 14, 2025 | msn.comVaso Corporation Announces Financial Results for Second Quarter of 2025August 14, 2025 | finance.yahoo.comVaso Corporation Announces Financial Results for Second Quarter of 2025 | VASO Stock NewsAugust 14, 2025 | gurufocus.comFirst Patient Dosed In Clinical Trial Of Therapy For Sickle DiseaseAugust 8, 2025 | msn.comSee More Headlines VASO Stock Analysis - Frequently Asked Questions How have VASO shares performed this year? Vaso's stock was trading at $0.1199 on January 1st, 2025. Since then, VASO shares have decreased by 3.3% and is now trading at $0.1160. How were Vaso's earnings last quarter? Vaso Corporation (OTCMKTS:VASO) posted its quarterly earnings data on Thursday, May, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $19.46 million during the quarter. Vaso had a negative trailing twelve-month return on equity of 1.14% and a negative net margin of 0.35%. How do I buy shares of Vaso? Shares of VASO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Vaso own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vaso investors own include Aramark (ARMK), AutoZone (AZO), Bank of America (BAC), Bristol Myers Squibb (BMY), Cisco Systems (CSCO), Intel (INTC) and Kimco Realty (KIM). Company Calendar Last Earnings5/15/2025Today8/29/2025Next Earnings (Estimated)11/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolOTCMKTS:VASO CIK839087 Webwww.vasocorporation.com Phone516-997-4600Fax516-997-2299Employees260Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$950 thousand Net Margins-0.35% Pretax Margin-0.02% Return on Equity-1.14% Return on Assets-0.38% Debt Debt-to-Equity RatioN/A Current Ratio1.51 Quick Ratio1.48 Sales & Book Value Annual Sales$83.05 million Price / Sales0.25 Cash Flow$0.01 per share Price / Cash Flow12.36 Book Value$0.15 per share Price / Book0.80Miscellaneous Outstanding Shares175,754,000Free Float97,537,000Market Cap$20.99 million OptionableNot Optionable Beta1.57 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (OTCMKTS:VASO) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaso Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaso With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.